ReP USP - Resultado da busca

Artigo de periodico
Human transcriptomic response to the VSV-vectored ebola vaccine (2021)
Santoro, Francesco ; Donato, Alessia; Lucchesi, Simone ; Sorgi, Sara ; Gerlini, Alice; Haks, Marielle C ; Ottenhoff, Tom H. M ; Dias, Patricia Gonzalez ; Nakaya, Helder Takashi Imoto ; Huttner, Angela; Siegrist, Claire-Anne; Medaglini, Donata; Pozzi, Gianni
Source: Vaccines. Unidade: FCF
Subjects: VÍRUS EBOLA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTORO, Francesco et al. Human transcriptomic response to the VSV-vectored ebola vaccine. Vaccines, v. 9, p. 1-15 art. 67, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9020067. Acesso em: 06 nov. 2024.
APA
Santoro, F., Donato, A., Lucchesi, S., Sorgi, S., Gerlini, A., Haks, M. C., et al. (2021). Human transcriptomic response to the VSV-vectored ebola vaccine. Vaccines, 9, 1-15 art. 67. doi:10.3390/vaccines9020067
NLM
Santoro F, Donato A, Lucchesi S, Sorgi S, Gerlini A, Haks MC, Ottenhoff THM, Dias PG, Nakaya HTI, Huttner A, Siegrist C-A, Medaglini D, Pozzi G. Human transcriptomic response to the VSV-vectored ebola vaccine [Internet]. Vaccines. 2021 ; 9 1-15 art. 67.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/vaccines9020067
Vancouver
Santoro F, Donato A, Lucchesi S, Sorgi S, Gerlini A, Haks MC, Ottenhoff THM, Dias PG, Nakaya HTI, Huttner A, Siegrist C-A, Medaglini D, Pozzi G. Human transcriptomic response to the VSV-vectored ebola vaccine [Internet]. Vaccines. 2021 ; 9 1-15 art. 67.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/vaccines9020067
Artigo de periodico
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood (2016)
Nakaya, Helder Takashi Imoto ; Clutterbuck, Elizabeth; Kazmin, Dmitri; Wang, Lili; Cortese, Mario; Bosinger, Steven E; Pate, Nirav B; Zak, Daniel E; Aderem, Alan; Dong, Tao; Giudice, Giuseppe Del; Rappuoli, Rino; Cerundolo, Vincenzo; Pollard, Andrew J; Pulendran, Bali; Siegrist, Claire-Anne
Source: Proceedingss of the National Academy of Sciences of the United States of America. Unidade: FCF
Subjects: IMUNIDADE, INFLUENZA, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKAYA, Helder Takashi Imoto et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proceedingss of the National Academy of Sciences of the United States of America, v. 113, n. 7, p. 1853-1858, 2016Tradução . . Disponível em: https://doi.org/10.1073/pnas.1519690113. Acesso em: 06 nov. 2024.
APA
Nakaya, H. T. I., Clutterbuck, E., Kazmin, D., Wang, L., Cortese, M., Bosinger, S. E., et al. (2016). Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proceedingss of the National Academy of Sciences of the United States of America, 113( 7), 1853-1858. doi:10.1073/pnas.1519690113
NLM
Nakaya HTI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Pate NB, Zak DE, Aderem A, Dong T, Giudice GD, Rappuoli R, Cerundolo V, Pollard AJ, Pulendran B, Siegrist C-A. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood [Internet]. Proceedingss of the National Academy of Sciences of the United States of America. 2016 ; 113( 7): 1853-1858.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1073/pnas.1519690113
Vancouver
Nakaya HTI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Pate NB, Zak DE, Aderem A, Dong T, Giudice GD, Rappuoli R, Cerundolo V, Pollard AJ, Pulendran B, Siegrist C-A. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood [Internet]. Proceedingss of the National Academy of Sciences of the United States of America. 2016 ; 113( 7): 1853-1858.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1073/pnas.1519690113
Artigo de periodico
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor 'beta'1 deficiency: medical and immunological implications (2003)
Fieschi, Claire; Dupuis, Stéphanie; Catherinot, Emilie; Feinberg, Jacqueline; Bustamente, Jacinta; Breiman, Adrien; Altare, Frédéric; Baretto, Richard; Le Deist, Françoise; Kayal, Samer; Koch, Hartmut; Richter, Darko; Brezina, Martin; Aksu, Guzide; Wood, Phil; Al-Jumaah, Suliman; Raspall, Miquel; Duarte, Alberto José da Silva; Tuerlinckx, David; Virelizier, Jean-Louis; Fischer, Alain; Enright, Andrea; Bernhöft, Jutta; Clearly, Aileen M.; Vermylen, Christiane; Rodriguez-Gallego, Carlos; Davies, Graham; Blütters-Sawatzki, Renate; Siegrist, Claire-Anne; Ehlayel, Mohammad; Novelli, Vas; Haas, Walther H.; Levy, Jacob; Freihorst, Joachim; Al-Hajjar, Sami; Nadal, David; Vasconcelos, Dewton de Moraes; Jeppsson, Olle; Kutukculer, Necil; Frecerova, Klara; Caragol, Isabel; Lammas, David; Kumararatne, Dinakantha; Abel, Laurent; Casanova, Jean-Laurent
Source: Journal of Experimental Medicine. Unidade: FM
Subjects: MICOBACTERIOSE, SALMONELLA, INTERFERONS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIESCHI, Claire et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor 'beta'1 deficiency: medical and immunological implications. Journal of Experimental Medicine, v. 197, n. 4, p. 527-535, 2003Tradução . . Acesso em: 06 nov. 2024.
APA
Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamente, J., Breiman, A., et al. (2003). Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor 'beta'1 deficiency: medical and immunological implications. Journal of Experimental Medicine, 197( 4), 527-535.
NLM
Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamente J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, Duarte AJ da S, Tuerlinckx D, Virelizier J-L, Fischer A, Enright A, Bernhöft J, Clearly AM, Vermylen C, Rodriguez-Gallego C, Davies G, Blütters-Sawatzki R, Siegrist C-A, Ehlayel M, Novelli V, Haas WH, Levy J, Freihorst J, Al-Hajjar S, Nadal D, Vasconcelos D de M, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne D, Abel L, Casanova J-L. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor 'beta'1 deficiency: medical and immunological implications. Journal of Experimental Medicine. 2003 ; 197( 4): 527-535.[citado 2024 nov. 06 ]
Vancouver
Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamente J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, Duarte AJ da S, Tuerlinckx D, Virelizier J-L, Fischer A, Enright A, Bernhöft J, Clearly AM, Vermylen C, Rodriguez-Gallego C, Davies G, Blütters-Sawatzki R, Siegrist C-A, Ehlayel M, Novelli V, Haas WH, Levy J, Freihorst J, Al-Hajjar S, Nadal D, Vasconcelos D de M, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne D, Abel L, Casanova J-L. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor 'beta'1 deficiency: medical and immunological implications. Journal of Experimental Medicine. 2003 ; 197( 4): 527-535.[citado 2024 nov. 06 ]

USP Schools

ReP

Filtros

Authors

Subjects

Non normalized affiliation

Countries of institutions of collaboration